Table 3.

The summation of success rate according to the mean PAS after treatment at 3, 6, 12 month follow-up in both study groups

	Group I (N = 85)			Group II (N = 86 )			P value
	3MS	6MS	12MS	3MS	6MS	12MS
aNo pain, N (%)	20 (23.52%)	18 (21.17%)	18 (21.17%)	21 (24.41%)	19 (22.09%)	18 (20.93%)	NS
bMinimal pain, N (%)	19 (22.35%)	19 (22.35%)	17 (20%)	20 (23.25%)	19 (22.09%)	18 (20.93%)	NS
cTolerable pain, N (%)	27 (31.76%)	28 (32.94%)	28 (32.94%)	27 (31.39%)	28 (32.55%)	27 (31.39%)	NS
dSevere pain, N (%)	19 (22.35%)	20 (23.52%)	22 (25.88%)	18 (20.93%)	21 (24.41%)	22 (25.58%)	NS
Overall success rate	(66/85) (77.64%)	(65/85) (76.47%)	(63/85) 74.11%	(68/86) 79.06%	(65/86) 75.58 %	(63/86) 73.25%	NS

NS not significant

^aexcellent = 10–9

^bgood = 6–8 PAS

^ctolerable = 3–5

^dminimal = 0–2 PAS